FDA approves generic pediatric antibiotic

Article

The Food and Drug Administration gave the okay to Ranbaxy Laboratories for its pediatric formulation of the generic antibiotic cefuroxime axetil.

The Food and Drug Administration gave the okay to Ranbaxy Laboratories for its pediatric formulation of the generic antibiotic cefuroxime axetil.

The drug, which is also sold as GlaxoSmithKline's Ceftin, is indicated for treatment of mild to moderate pharyngitis/tonsillitis, acute bacterial otitis media, and impetigo in patients 3 months to 12 years old. Two dose sizes have been approved, 125 mg/5 ml and 250 mg/5 ml.

Related Videos
James Wallace, MD | Image Credit: Provided by James Wallace, MD
Image Credit: Marcibowers.com
Rob Knight, PhD | Image Credit: Contemporary Pediatrics®
Tammy Brady, MD, PhD | Image credit: Provided by guest
Tina Tan, MD, FAAP, FIDSA, FPIDS, editor in chief, Contemporary Pediatrics, professor of pediatrics, Feinberg School of Medicine, Northwestern University, pediatric infectious diseases attending, Ann & Robert H. Lurie Children's Hospital of Chicago
Related Content
© 2023 MJH Life Sciences

All rights reserved.